NO20075650L - Tri- eller tetrasubstituterte 3-aminopyrrolidinderivater - Google Patents

Tri- eller tetrasubstituterte 3-aminopyrrolidinderivater

Info

Publication number
NO20075650L
NO20075650L NO20075650A NO20075650A NO20075650L NO 20075650 L NO20075650 L NO 20075650L NO 20075650 A NO20075650 A NO 20075650A NO 20075650 A NO20075650 A NO 20075650A NO 20075650 L NO20075650 L NO 20075650L
Authority
NO
Norway
Prior art keywords
hydrogen atom
carbon atoms
alkyl group
group containing
represent
Prior art date
Application number
NO20075650A
Other languages
English (en)
Norwegian (no)
Inventor
Hisashi Takahashi
Rie Miyauchi
Makoto Takemura
Hiroaki Inagaki
Satoshi Komoriya
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37431361&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20075650(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of NO20075650L publication Critical patent/NO20075650L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20075650A 2005-05-19 2007-11-06 Tri- eller tetrasubstituterte 3-aminopyrrolidinderivater NO20075650L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2005146386 2005-05-19
JP2005344514 2005-11-29
JP2006080629 2006-03-23
PCT/JP2006/310069 WO2006123792A1 (ja) 2005-05-19 2006-05-19 トリ－、テトラ－置換－３－アミノピロリジン誘導体

Publications (1)

Publication Number Publication Date
NO20075650L true NO20075650L (no) 2007-12-13

Family

ID=37431361

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075650A NO20075650L (no) 2005-05-19 2007-11-06 Tri- eller tetrasubstituterte 3-aminopyrrolidinderivater

Country Status (16)

Country Link
US (3) US7563805B2 (de)
EP (2) EP1882689B1 (de)
JP (2) JP5087394B2 (de)
KR (1) KR101307717B1 (de)
AR (1) AR054272A1 (de)
AU (1) AU2006248354B2 (de)
BR (1) BRPI0610114A2 (de)
CA (1) CA2608468C (de)
ES (1) ES2422858T3 (de)
HK (1) HK1116774A1 (de)
IL (1) IL186815A (de)
MY (1) MY143605A (de)
NO (1) NO20075650L (de)
NZ (1) NZ562959A (de)
TW (1) TWI384987B (de)
WO (1) WO2006123792A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1757598A4 (de) * 2004-05-13 2010-07-21 Daiichi Seiyaku Co Substituiertes pyrrolidinderivat
TW200640899A (en) * 2005-01-21 2006-12-01 Daiichi Seiyaku Co Fluoroalkylpyrrolidine derivative
US7563805B2 (en) 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative
WO2006123767A1 (ja) * 2005-05-20 2006-11-23 Daiichi Sankyo Company, Limited 不斉四置換炭素原子含有化合物の製法
JPWO2007037330A1 (ja) * 2005-09-28 2009-04-09 第一三共株式会社 キノロン含有凍結乾燥製剤の製造方法
US7842818B2 (en) * 2005-09-28 2010-11-30 Daiichi Sankyo Company, Limited Process for preparation of tetrasubstituted 5-azaspiro[2.4]- heptane derivatives and optically active intermediates thereof
US7977346B2 (en) 2006-01-17 2011-07-12 Guoqing Paul Chen Spiro compounds and methods of use
TWI386401B (zh) * 2006-03-27 2013-02-21 Daiichi Seiyaku Co 醫藥用水合物
RU2443698C2 (ru) * 2007-01-05 2012-02-27 Дайити Санкио Компани, Лимитед Конденсированное замещенное производное аминопирролидина
JP5174365B2 (ja) * 2007-03-23 2013-04-03 第一三共株式会社 キノロン含有凍結乾燥製剤の製造方法
MX2010003056A (es) 2007-09-21 2010-04-07 Epiphany Biosciences Inc Polimorfos de valomaciclovir.
US9359303B2 (en) 2009-04-21 2016-06-07 Purdue Research Foundation Octahydrobenzoisoquinoline modulators of dopamine receptors and uses therefor
JP5669984B2 (ja) * 2011-05-18 2015-02-18 エナンタ ファーマシューティカルズ インコーポレイテッド ５−アザスピロ［２．４］ヘプタン−６−カルボン酸およびその誘導体の製造方法
KR20150112940A (ko) 2013-01-25 2015-10-07 가부시기가이샤 아이 에이 아이 액추에이터
WO2019025250A1 (en) 2017-08-04 2019-02-07 Basf Se SUBSTITUTED TRIFLUOROMETHYLOXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5872589A (ja) 1981-10-28 1983-04-30 Dai Ichi Seiyaku Co Ltd ピリド〔１，２，３−ｄｅ〕〔１，４〕ベンゾオキサジン誘導体
US4822801A (en) 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
IE58742B1 (en) 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
JPS61137885A (ja) 1984-12-08 1986-06-25 Dainippon Pharmaceut Co Ltd １，８−ナフチリジン誘導体、そのエステルおよびその塩
JPS61152682A (ja) 1984-12-27 1986-07-11 Dainippon Pharmaceut Co Ltd ピリドンカルボン酸誘導体、そのエステルおよびその塩
JPS61282382A (ja) 1985-06-06 1986-12-12 Dainippon Pharmaceut Co Ltd フエニル置換１，８−ナフチリジン誘導体、そのエステルおよびその塩
JPH0635457B2 (ja) * 1985-06-28 1994-05-11 杏林製薬株式会社 ピリドンカルボン酸誘導体およびその製造方法
US4735949A (en) * 1986-02-18 1988-04-05 Warner-Lambert Company Disubstituted-7-pyrrolidinonaphthyridine antibacterial agents
JPS63198664A (ja) * 1986-03-31 1988-08-17 Sankyo Co Ltd キノロンカルボン酸誘導体
EP0242789A3 (de) 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Chinolinderivate und Verfahren zu ihrer Herstellung
JPS63152318A (ja) 1986-08-07 1988-06-24 Dainippon Pharmaceut Co Ltd 抗マイコプラズマ剤
ZW16387A1 (en) * 1986-09-12 1988-05-25 Hoffmann La Roche Tricyclic compounds
ES2059335T3 (es) 1986-09-12 1994-11-16 Hoffmann La Roche Derivados de pirido(3,2,1-ij)-1,3,4-benzoxadiazina, procedimiento para su obtencion, preparados farmaceuticos correspondientes y productos intermedios utilizables en el procedimiento.
NZ222047A (en) 1986-10-08 1991-01-29 Bristol Myers Co Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
JPS63130594A (ja) 1986-11-21 1988-06-02 Tokyo Tanabe Co Ltd ベンゾ〔ｉｊ〕キノリジン−２−カルボン酸化合物及びその製造法
JPS63188626A (ja) 1987-01-30 1988-08-04 Dainippon Pharmaceut Co Ltd ピリドンカルボン酸の可溶化方法
IL90062A (en) 1988-04-27 1994-10-07 Daiichi Seiyaku Co History of pyridonecarboxylic acid, their preparation and pharmaceutical preparations containing them
US5286723A (en) * 1988-08-31 1994-02-15 Daiichi Seiyaku Co., Ltd. Spiro compound
JP2807277B2 (ja) 1988-08-31 1998-10-08 第一製薬株式会社 スピロ化合物
CA1336090C (en) 1988-08-31 1995-06-27 Isao Hayakawa Spiro-substituted cyclic amines of quinolone derivatives
US5324735A (en) * 1989-07-21 1994-06-28 Ss Pharmaceutical Co., Ltd. Quinoline carboxylic acid derivatives
JP2991381B2 (ja) 1990-07-16 1999-12-20 大日本製薬株式会社 新規キノリンカルボン酸誘導体、そのエステルおよびその塩
KR920004385A (ko) 1990-08-09 1992-03-27 와꾸나가 기스께 신규 삼환화합물 또는 그의 염, 이의 제조방법 및 이를 함유하는 항균제
JPH0559052A (ja) * 1990-08-09 1993-03-09 Wakunaga Pharmaceut Co Ltd 新規三環性化合物又はその塩及びこれを含有する抗菌剤
ES2151488T3 (es) * 1991-05-28 2001-01-01 Daiichi Seiyaku Co Derivado de acido piridonacarboxilico.
US5468742A (en) 1991-07-19 1995-11-21 Bayer Aktiengesellschaft 8-vinyl- and 9-ethinyl-quinolone-carboxylic acids
DE4123918A1 (de) 1991-07-19 1993-01-21 Bayer Ag 8-vinyl- und 8-ethinyl-chinoloncarbonsaeuren
KR930703292A (ko) 1991-12-27 1993-11-29 쿠사이 요시히로 신규 퀴놀론 유도체 또는 그의 염 및 이 화합물을 함유하는 항균제
JPH05279364A (ja) 1992-02-07 1993-10-26 Wakunaga Pharmaceut Co Ltd 新規三環性化合物又はその塩及びこれを含有する抗菌剤
WO1993025545A1 (en) * 1992-06-09 1993-12-23 Korea Research Institute Of Chemical Technology Novel quinoline derivatives and processes for preparing the same
JPH06228138A (ja) 1993-02-03 1994-08-16 Fujisawa Pharmaceut Co Ltd ピリドシンノリン化合物またはその塩及びこれを含有する抗菌剤
TW273551B (de) 1993-05-24 1996-04-01 Wakiei Seiyaku Kk
JPH0725873A (ja) 1993-07-09 1995-01-27 Wakunaga Pharmaceut Co Ltd キノロン誘導体又はその塩並びに該化合物を含有する抗菌剤
EP0787726B1 (de) 1994-06-14 2001-11-28 Dainippon Pharmaceutical Co., Ltd. Neue verbindung, verfahren zu ihrer herstellung und antitumormittel
EP0787720B1 (de) 1994-10-20 2003-07-16 Wakunaga Seiyaku Kabushiki Kaisha Pyridoncarboxylat- derivate oder salze davon und antibakterielle zusammensetzungen die diese als aktiven bestandteil enthalten
CA2211681C (en) 1995-01-30 2003-05-13 Wakunaga Seiyaku Kabushiki Kaisha Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents comprising the same as active ingredient
JP4323574B2 (ja) 1995-12-13 2009-09-02 大日本住友製薬株式会社 抗腫瘍剤
KR20010014209A (ko) * 1997-06-24 2001-02-26 스즈키 다다시 시스-치환된 플루오로메틸피롤리딘 유도체
IL152759A0 (en) * 2000-03-31 2003-06-24 Daiichi Seiyaku Co Quinolonecarboxylic acid derivatives
US20070191356A1 (en) 2004-02-02 2007-08-16 Makoto Takemura Pyridobenzoxazine derivative
EP1757598A4 (de) 2004-05-13 2010-07-21 Daiichi Seiyaku Co Substituiertes pyrrolidinderivat
US7563805B2 (en) 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative

Also Published As

Publication number Publication date
ES2422858T3 (es) 2013-09-16
TW200716131A (en) 2007-05-01
NZ562959A (en) 2010-07-30
AU2006248354B2 (en) 2011-11-03
WO2006123792A1 (ja) 2006-11-23
HK1116774A1 (en) 2009-01-02
EP1882689B1 (de) 2013-07-10
US20120232288A1 (en) 2012-09-13
TWI384987B (zh) 2013-02-11
EP1882689A4 (de) 2010-01-06
CA2608468C (en) 2013-02-26
US8211910B2 (en) 2012-07-03
JP2012193195A (ja) 2012-10-11
US20090253726A1 (en) 2009-10-08
JPWO2006123792A1 (ja) 2008-12-25
MY143605A (en) 2011-06-15
IL186815A0 (en) 2008-02-09
KR101307717B1 (ko) 2013-09-11
EP1882689A1 (de) 2008-01-30
JP5475841B2 (ja) 2014-04-16
IL186815A (en) 2013-09-30
BRPI0610114A2 (pt) 2010-06-01
AR054272A1 (es) 2007-06-13
KR20080020603A (ko) 2008-03-05
JP5087394B2 (ja) 2012-12-05
US7563805B2 (en) 2009-07-21
AU2006248354A1 (en) 2006-11-23
US20060264428A1 (en) 2006-11-23
EP2463274A1 (de) 2012-06-13
US8476429B2 (en) 2013-07-02
CA2608468A1 (en) 2006-11-23

Similar Documents

Publication Publication Date Title
NO20075650L (no) Tri- eller tetrasubstituterte 3-aminopyrrolidinderivater
NO20075312L (no) N-(N-sulfonylaminometyl)cyklopropankarboksamidderivater nyttige ved smertebehandling
TW200504180A (en) Light-emitting element and iridium complex
CY1117392T1 (el) Ενδιαμεσες ενωσεις για την παρασκευη μακροκυκλικων αναστολεων του ιου της ηπατιτιδας c
NO20054425L (no) Heteroarylkarbamoylbenzenderivater
TW200745034A (en) New compounds
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
WO2007079186A3 (en) 1, 3-oxazolidin-2-one derivatives useful as cetp inhibitors
MY172034A (en) Intermediate for producing bicyclic ?-amino acid derivative
MY146646A (en) 2,3-dihydro-6-nitroimidazo [2,1-b] oxazole compounds for the treatment of tuberculosis
MX2009010024A (es) Nuevo compuesto de adenina.
JO3261B1 (ar) مشتق بيريدين أحادي الحلقة
MX2009006397A (es) Derivados de imidazotiazol.
NO20062617L (no) Anvendelse av glukosidase inhibitorer for terapi av mucovisidose
MX2009013728A (es) Derivados de bicicloanilina.
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
TR200401413T1 (tr) Dibenzilamin bileşikleri ve bunların farmasötik kullanımları
NO20054135L (no) Kipolinon/benzoksazin derivater og anvendelser derav
CY1117923T1 (el) Αζωτουχος ετεροκυκλικη ενωση και γεωργικο ή κηπουρικο μυκητοκτονο
PH12020552000A1 (en) Polycyclic carbamoylpyridone derivative
MY169179A (en) Novel piperidine compound or salt thereof
MY148980A (en) Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
TW200637870A (en) Novel pyrimidine nucleoside compound and salt thereof
MX2011007598A (es) Derivados de imidazotiazol que tienen estructura de anillo de prolina.
DK0477903T3 (da) Substituerede 4-amino-3-pyridinoler, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application